Strength
325 mg/1
Manufacturer
McKessonNDC
63739008702
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
7/12/2021
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 225 times since Dec 15, 2021, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0262 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0208 (May 18, 2022) |
| 52-week high | $0.0267 |
| 52-week low | $0.0259 |
| Median price | $0.0243 |
| Average price | $0.0243 |
| Largest weekly change | +21.2% (Jun 22, 2022) |
| Weeks tracked | 225 |
| Tracking since | Dec 15, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+1.2%
3Y
+12.6%
5Y
N/A
All
+6.0%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen 325mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
McKesson manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen 325mg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by McKesson, is $0.0262 per EA (NDC 63739008702), effective Apr 1, 2026.
How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 6.0%. It has been tracked across 225 weekly CMS publications since Dec 15, 2021.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?
Since Dec 15, 2021, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0208 (May 18, 2022) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0243 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ACETAMINOPHEN 325 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ACETAMINOPHEN 325 MG TABLET?
ACETAMINOPHEN 325 MG TABLET (NDC 63739008702) is labeled by McKesson, and CMS classifies it as a generic product.